{"id":138835,"date":"2021-09-27T08:00:00","date_gmt":"2021-09-27T08:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2919387"},"modified":"2021-09-27T08:00:00","modified_gmt":"2021-09-27T08:00:00","slug":"insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/","title":{"rendered":"Insights into Gonorrhea Treatment Market, Epidemiology, Emerging Therapies, and Key Companies Working in the Domain During the Study Period (2018-30) in the 7MM | DelveInsight"},"content":{"rendered":"<p><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"5353 Delveinsight\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" title=\"Insights into Gonorrhea Treatment Market, Epidemiology, Emerging Therapies, and Key Companies Working in the Domain During the Study Period (2018-30) in the 7MM | DelveInsight 3\"><\/p>\n<p><span style=\"font-weight: 400;\"><img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/delveinsight\/Gonorrhea-Market-Insights.jpg?1632714463221\" alt=\"Gonorrhea-Market-Insights\" width=\"678\" height=\"356\" title=\"Insights into Gonorrhea Treatment Market, Epidemiology, Emerging Therapies, and Key Companies Working in the Domain During the Study Period (2018-30) in the 7MM | DelveInsight 4\"><\/span><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsigth&rsquo;s <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/gonorrhea-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Gonorrhea market report<\/strong><\/a><span style=\"font-weight: 400;\"> offers comprehensive coverage of the <\/span><span style=\"font-weight: 400;\">current treatment practices, emerging d<\/span><span style=\"font-weight: 400;\">rugs, Gonorrhea market share of the individual therapies, current and forecasted Gonorrhea market size from 2018 to 2030 segmented into <\/span><span style=\"font-weight: 400;\">7MM (<\/span><span style=\"font-weight: 400;\">the United States, EU5 (Germany, Spain, Italy, France, and the UK), and Japan).<\/span><\/p>\n<p><strong>Key Highlights from the <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/gonorrhea-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Gonorrhea Market Report<\/strong><\/a><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">According to the Centers for Disease Control and Prevention (CDC), Gonorrhea is the second most commonly reported notifiable disease in the United States. Over <\/span><strong>580,000<\/strong><span style=\"font-weight: 400;\"> Gonorrhea cases were reported in the United States in 2018.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">According to Kirkcaldy et al. (2019), Gonorrhea prevalence among women was highest in the <\/span><strong>Americas (0.9 percent) and lowest in Europe (0.3 percent )<\/strong><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Key pharmaceutical companies such as <\/span><strong>Evofem Biosciences<\/strong><span style=\"font-weight: 400;\">, <\/span><strong>GlaxoSmithKline<\/strong><span style=\"font-weight: 400;\">, <\/span><strong>Entasis Therapeutics, GARDP,<\/strong><span style=\"font-weight: 400;\"> and others are developing therapies for Gonorrhea.&nbsp;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Key pipeline therapies in the Gonorrhea therapeutics market include <\/span><strong>EVO100, Gepotidacin (GSK2140944), Zoliflodacin (ETX0914), <\/strong><span style=\"font-weight: 400;\">and several others.<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>EVO100 <\/strong><span style=\"font-weight: 400;\">is an investigational drug candidate developed by <\/span><strong>Evofem Biosciences<\/strong><span style=\"font-weight: 400;\">. It is a vaginal gel that is intended to reduce certain vaginal infections by balancing vaginal pH, thereby maintaining healthy vaginal flora and creating an environment that is detrimental to the growth and proliferation of harmful bacteria.<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Gepotidacin (GSK2140944)<\/strong><span style=\"font-weight: 400;\"> is a novel triaza acenaphthylene topoisomerase inhibitor antibiotic developed by <\/span><strong>GSK <\/strong><span style=\"font-weight: 400;\">with a novel &ldquo;dual targeting&rdquo; mechanism of action and oral formulation.<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Zoliflodacin (ETX0914)<\/strong><span style=\"font-weight: 400;\"> is the first of a novel class of molecules developed for the treatment of uncomplicated gonorrhea. <\/span><strong>Entasis <\/strong><span style=\"font-weight: 400;\">collaborated with the <\/span><strong>Global Antibiotic Research and Development Partnership (GARDP) <\/strong><span style=\"font-weight: 400;\">to develop Zoliflodacin<\/span><strong>.<\/strong><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Request for the Webex demo of the report @ <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/gonorrhea-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Gonorrhea Market Outlook<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/gonorrhea-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>The Gonorrhea market report<\/strong><\/a><span style=\"font-weight: 400;\"> also discusses current Gonorrhea treatment practices\/algorithms, Gonorrhea market drivers, Gonorrhea market barriers, and unmet medical needs.<\/span><\/p>\n<p><strong>Gonorrhea Overview<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Gonorrhea is a sexually transmitted disease (STD) caused by a bacterium called <\/span><em><span style=\"font-weight: 400;\">Neisseria gonorrhoeae<\/span><\/em><span style=\"font-weight: 400;\">. <\/span><em><span style=\"font-weight: 400;\">N. gonorrhoeae<\/span><\/em><span style=\"font-weight: 400;\"> infects the reproductive tract&#8217;s mucous membranes, including the cervix, uterus, and fallopian tubes in women and the urethra in both men and women. <\/span><em><span style=\"font-weight: 400;\">N. gonorrhoeae<\/span><\/em><span style=\"font-weight: 400;\"> can also infect the mouth, throat, eyes, and rectum&#8217;s mucous membranes.<\/span><\/p>\n<p><strong>Gonorrhea Epidemiology Segmentation<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">The Gonorrhea report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Gonorrhea Total Prevalent Cases<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Gonorrhea Total Diagnosed Cases&nbsp;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Gonorrhea Age-Specific Cases<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Gonorrhea Gender-Specific Cases<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Gonorrhea Total Treated Cases<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Get the complete epidemiology segmentation analysis @ <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/gonorrhea-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Gonorrhea Epidemiology Analysis<\/strong><\/a><\/p>\n<p><strong>Gonorrhea Treatment Landscape<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">There are antibiotic treatments available for Gonorrhea treatments. Because some strains of Gonorrhea have been found to be resistant to certain drugs, the recommended treatment for the majority of cases consists of two antibiotics: one administered via injection and the other via oral medication (usually just a single pill). The antibiotics that are used for Gonorrhea treatment are <\/span><strong>Ceftriaxone <\/strong><span style=\"font-weight: 400;\">and <\/span><strong>Azithromycin.<\/strong><\/p>\n<p><strong>&nbsp;<\/strong><span style=\"font-weight: 400;\">Get more details about the current gonorrhea treatment @ <\/span><strong>Gonorrhea Treatment Guidelines<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/gonorrhea-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Gonorrhea Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">The Gonorrhea market size will expand during the forecast period, 2021&ndash;2030, due to the rising prevalence of Gonorrhea. The Gonorrhea market is expected to grow in size due to the launch of emerging therapies such as <\/span><strong>EVO100, Gepotidacin, <\/strong><span style=\"font-weight: 400;\">and others during the study period (2018-30).<\/span><\/p>\n<p><strong>Gonorrhea Pipeline Therapies and Key Companies<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">EVO100: Evofem Biosciences<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Gepotidacin: GlaxoSmithKline<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Zoliflodacin: Entasis\/GARDP<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Learn more about the emerging drugs and companies @ <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/gonorrhea-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Gonorrhea Therapeutics Market<\/strong><\/a><span style=\"font-weight: 400;\">&nbsp;<\/span><\/p>\n<p><strong>Gonorrhea Market Drivers<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Increasing prevalence of Gonorrhea<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Improved awareness on Gonorrhea and STDs<\/span><\/li>\n<\/ul>\n<p><strong>Gonorrhea Market Barriers<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Some strains of gonorrhea have been found to be resistant to certain drugs conferring antibiotic resistance<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">The low voluntary screening rate for the disease<\/span><strong>&nbsp;<\/strong><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/gonorrhea-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Scope of the Report<\/strong><\/a><\/p>\n<p><strong>Coverage: <\/strong><span style=\"font-weight: 400;\">7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)<\/span><\/p>\n<p><strong>Study Period: <\/strong><span style=\"font-weight: 400;\">2018-30<\/span><\/p>\n<p><strong>Gonorrhea Key Companies: <\/strong><span style=\"font-weight: 400;\">Evofem Biosciences, GlaxoSmithKline, Entasis Therapeutics, GARDP, among others.<\/span><strong>&nbsp;<\/strong><\/p>\n<p><strong>Gonorrhea Key Pipeline Therapies:<\/strong><span style=\"font-weight: 400;\"> EVO100, Gepotidacin (GSK2140944), Zoliflodacin (ETX0914),<\/span> <span style=\"font-weight: 400;\">and others.<\/span><\/p>\n<p><strong>Gonorrhea Segmentation: <\/strong><span style=\"font-weight: 400;\">By Geography, Gonorrhea drugs<\/span><\/p>\n<p><strong>Analysis: <\/strong><span style=\"font-weight: 400;\">Comparative and conjoint analysis of <\/span><span style=\"font-weight: 400;\">&nbsp;Gonorrhea<\/span><span style=\"font-weight: 400;\"> emerging therapies<\/span><\/p>\n<p><strong>Tools Used: <\/strong><span style=\"font-weight: 400;\">SWOT Analysis<\/span><\/p>\n<p><strong>Case Studies<\/strong><\/p>\n<p><strong>KOL&rsquo;s Views<\/strong><\/p>\n<p><strong>Analyst&rsquo;s Views<\/strong><\/p>\n<p><strong>Table of Contents<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">1.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Key Insights<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">2.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Executive Summary of Gonorrhea<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">3.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">SWOT Analysis of Gonorrhea<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">4.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea: Market Share (%) Distribution Overview at a Glance: By Country<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">5.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea Epidemiology and Market Methodology<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">6.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea: Disease Background and Overview<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">7.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea Epidemiology and Patient Population<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">8.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea Epidemiology Scenario: 7MM<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">9.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea The United States Epidemiology<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">10.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea EU-5 Epidemiology<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">11.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea Japan Epidemiology<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">12.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea Current Treatment Practices<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">13.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea Unmet Needs<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">14.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Patient Journey of Gonorrhea<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">15.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Key Endpoints in Gonorrhea Clinical Trials<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">16.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea Marketed Therapies<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">17.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea Emerging Therapies<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">18.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Conjoint Analysis of Gonorrhea<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">19.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea: Seven Major Market Analysis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">20.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea 7MM Market Size<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">21.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea United States Market Size<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">22.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea EU-5 Market Size<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">23.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea Japan Market Size<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">24.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Market Access and Reimbursement of Gonorrhea Therapies<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">25.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea Market Drivers<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">26.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Gonorrhea Market Barriers<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">27.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Appendix<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">28.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">DelveInsight Capabilities<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">29.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Disclaimer<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">30.<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">About DelveInsight<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">Know more about report offerings @ <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/gonorrhea-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Gonorrhea Market Research<\/strong><\/a><\/p>\n<p><strong>Related Reports<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/multi-drug-resistant-mdr-neisseria-gonorrhoeae-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae, historical and forecasted epidemiology as well as the Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/human-papillomavirus-hpv-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Human Papillomavirus<\/strong><strong> Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Human Papillomavirus<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Inovio Pharmaceuticals, ISA Pharmaceuticals, Vaccibody A\/S, <\/strong><span style=\"font-weight: 400;\">among others.&nbsp;<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/human-papillomavirus-hpv-associated-disorders-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Human Papillomavirus (HPV) Associated Disorders Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Human Papillomavirus (HPV) Associated Disorders &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Human Papillomavirus (HPV) Associated Disorders, historical and forecasted epidemiology as well as the Human Papillomavirus (HPV) Associated Disorders market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/hpv-induced-cutaneous-tumors-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>HPV-induced Cutaneous Tumors Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;HPV-induced Cutaneous Tumors &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the HPV-induced Cutaneous Tumors, historical and forecasted epidemiology as well as the HPV-induced Cutaneous Tumors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/human-papillomavirus-16-positive-hpv16-cancers-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Human Papillomavirus<\/strong><strong> 16+ Cancers Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Human Papillomavirus<\/span><span style=\"font-weight: 400;\"> 16+ Cancers Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Merck, GlaxoSmithKline, PDS Biotechnology, Merck, Cue Biopharma, ISA Pharmaceuticals, Regeneron Pharmaceuticals, Vaccibody AS, Roche, <\/strong><span style=\"font-weight: 400;\">among others.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">&nbsp;<\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/dysmenorrhea-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Dysmenorrhea<\/strong><strong> Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Dysmenorrhea<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>AbbVie, Neurosciences Biosciences, Nobelpharma, ASKA Pharmaceutical, ObsEva, Myovant Sciences, Takeda,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/erectile-dysfunction-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Erectile Dysfunction Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Erectile Dysfunction &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Erectile Dysfunction, historical and forecasted epidemiology as well as the Erectile Dysfunction market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/uterine-fibroids-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Uterine Fibroids Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Uterine Fibroids &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Uterine fibroids, historical and forecasted epidemiology as well as the Uterine fibroids market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/anovulation-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Anovulation Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Anovulation Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Anovulation, historical and forecasted epidemiology as well as the Anovulation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/prostate-cancer-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Prostate Cancer Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Prostate Cancer<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Bayer Health Care, Astellas Pharma, Amgen, Janssen Pharmaceutical, Sanofi, Orion Corporation,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><strong>For rich insights into Healthcare and Pharmaceutical News, visit <\/strong><a href=\"https:\/\/www.delveinsight.com\/consulting\/market-assessment-services?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"><strong>Pharma, Healthcare, and Biotech Blog Posts<\/strong><\/a><\/p>\n<p><strong>About<a href=\"https:\/\/www.delveinsight.com\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"> DelveInsight<\/a><\/strong><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.&nbsp;<br \/><\/span><span style=\"font-weight: 400;\">Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform<\/span><a href=\"https:\/\/www.pharmdelve.com\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\" target=\"_blank\" rel=\"noopener\"> <strong>PharmDelve<\/strong><span style=\"font-weight: 400;\">.<\/span><\/a><\/p>\n<p><strong>Connect With Us at:<br \/><\/strong><a href=\"https:\/\/www.linkedin.com\/company\/delveinsight-business-research-llp\/\" target=\"_blank\" rel=\"noopener\"><strong>LinkedIn<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/www.facebook.com\/delveinsightindia\/\" target=\"_blank\" rel=\"noopener\"> <strong>Facebook<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/twitter.com\/delve_insight\" target=\"_blank\" rel=\"noopener\"> <strong>Twitter<\/strong><\/a><\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/gonorrhea-therapies\/\" rel=\"tag noopener\" target=\"_blank\">Gonorrhea Therapies<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/gonorrhea-pipeline\/\" rel=\"tag noopener\" target=\"_blank\">Gonorrhea Pipeline<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/gonorrhea-epidemiology\/\" rel=\"tag noopener\" target=\"_blank\">Gonorrhea Epidemiology<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/gonorrhea-therapeutics\/\" rel=\"tag noopener\" target=\"_blank\">Gonorrhea Therapeutics<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/gonorrhea-treatment\/\" rel=\"tag noopener\" target=\"_blank\">Gonorrhea Treatment<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/gonorrhea-market\/\" rel=\"tag noopener\" target=\"_blank\">Gonorrhea Market<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/gonorrhea\/\" rel=\"tag noopener\" target=\"_blank\">Gonorrhea<\/a> <\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.delveinsight.com\/<\/a><br \/><b>Contact Information:<\/b><br \/>Sandeep Joshi\u00a0 info@delveinsight.com\u00a0 +1(919)321-6187\u00a0<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag noopener\" target=\"_blank\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag noopener\" target=\"_blank\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/menafn\/\" rel=\"category tag noopener\" target=\"_blank\">Menafn<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/pr-wirein\/\" rel=\"category tag noopener\" target=\"_blank\">PR-Wirein<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn-internal-distribution\/\" rel=\"category tag noopener\" target=\"_blank\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag noopener\" target=\"_blank\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag noopener\" target=\"_blank\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag noopener\" target=\"_blank\">English<\/a><\/p>\n<\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Sandeep Joshi\u00a0 info@delveinsight.com\u00a0 +1(919)321-6187\u00a0<\/p>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsigth&rsquo;s Gonorrhea market report offers comprehensive coverage of the current treatment practices, emerging drugs, Gonorrhea market share of the individual therapies, current and forecasted Gonorrhea market size from 2018 to 2030 segmented into 7MM (the United States, EU5 (Germany, Spain, Italy, France, and the UK), and Japan). Key Highlights from the Gonorrhea Market Report According [&hellip;] <a href=\"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-138835","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Insights into Gonorrhea Treatment Market, Epidemiology, Emerging Therapies, and Key Companies Working in the Domain During the Study Period (2018-30) in the 7MM | DelveInsight - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insights into Gonorrhea Treatment Market, Epidemiology, Emerging Therapies, and Key Companies Working in the Domain During the Study Period (2018-30) in the 7MM | DelveInsight - Business\" \/>\n<meta property=\"og:description\" content=\"DelveInsigth&rsquo;s Gonorrhea market report offers comprehensive coverage of the current treatment practices, emerging drugs, Gonorrhea market share of the individual therapies, current and forecasted Gonorrhea market size from 2018 to 2030 segmented into 7MM (the United States, EU5 (Germany, Spain, Italy, France, and the UK), and Japan). Key Highlights from the Gonorrhea Market Report According [&hellip;] Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-27T08:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/\",\"name\":\"Insights into Gonorrhea Treatment Market, Epidemiology, Emerging Therapies, and Key Companies Working in the Domain During the Study Period (2018-30) in the 7MM | DelveInsight - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\",\"datePublished\":\"2021-09-27T08:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insights into Gonorrhea Treatment Market, Epidemiology, Emerging Therapies, and Key Companies Working in the Domain During the Study Period (2018-30) in the 7MM | DelveInsight\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Insights into Gonorrhea Treatment Market, Epidemiology, Emerging Therapies, and Key Companies Working in the Domain During the Study Period (2018-30) in the 7MM | DelveInsight - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/","og_locale":"en_US","og_type":"article","og_title":"Insights into Gonorrhea Treatment Market, Epidemiology, Emerging Therapies, and Key Companies Working in the Domain During the Study Period (2018-30) in the 7MM | DelveInsight - Business","og_description":"DelveInsigth&rsquo;s Gonorrhea market report offers comprehensive coverage of the current treatment practices, emerging drugs, Gonorrhea market share of the individual therapies, current and forecasted Gonorrhea market size from 2018 to 2030 segmented into 7MM (the United States, EU5 (Germany, Spain, Italy, France, and the UK), and Japan). Key Highlights from the Gonorrhea Market Report According [&hellip;] Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/","og_site_name":"Business","article_published_time":"2021-09-27T08:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/","url":"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/","name":"Insights into Gonorrhea Treatment Market, Epidemiology, Emerging Therapies, and Key Companies Working in the Domain During the Study Period (2018-30) in the 7MM | DelveInsight - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png","datePublished":"2021-09-27T08:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2021\/09\/27\/insights-into-gonorrhea-treatment-market-epidemiology-emerging-therapies-and-key-companies-working-in-the-domain-during-the-study-period-2018-30-in-the-7mm-delveinsight\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Insights into Gonorrhea Treatment Market, Epidemiology, Emerging Therapies, and Key Companies Working in the Domain During the Study Period (2018-30) in the 7MM | DelveInsight"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/138835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=138835"}],"version-history":[{"count":7,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/138835\/revisions"}],"predecessor-version":[{"id":139247,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/138835\/revisions\/139247"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=138835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=138835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=138835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}